Literature DB >> 9659254

Ulcerative colitis and perinuclear antineutrophil cytoplasmic antibodies.

P C Doré.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659254      PMCID: PMC500686          DOI: 10.1136/jcp.51.4.343

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

1.  [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].

Authors:  A Schnabel; E Csernok; H Schultz; M Stoffel; C Herzberg; S F Carroll; W L Gross
Journal:  Med Klin (Munich)       Date:  1997-07-15

2.  Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Authors:  D S Bansi; R W Chapman; K A Fleming
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-09       Impact factor: 2.566

3.  Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2.

Authors:  J Sobajima; S Ozaki; F Osakada; H Uesugi; H Shirakawa; M Yoshida; K Nakao
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

4.  Atypical perinuclear antineutrophil cytoplasmic antibodies after colectomy in inflammatory bowel disease.

Authors:  H J Freeman; B Roeck; D V Devine; C J Carter
Journal:  Can J Gastroenterol       Date:  1997 May-Jun       Impact factor: 3.522

5.  Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.

Authors:  R S Walmsley; M H Zhao; M I Hamilton; A Brownlee; P Chapman; R E Pounder; A J Wakefield; C M Lockwood
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.